Highlights include the presentation of 12-month follow-up data from first randomized controlled trial of Transoral Incisionless Fundoplication (TIF®) procedure with the EsophyX® device
SAN MATEO, Calif. (April 28, 2014) EndoGastric Solutions® (EGS), the leader in endoluminal reconstructive treatment for gastroesophageal reflux disease (GERD), today announced that the first 12-month follow up data from a prospective, controlled study of Transoral Incisionless Fundoplication (TIF®) procedure with the EsophyX® device will be presented at Digestive Disease Week® (DDW) 2014.
On Monday, May 5 at 2:30 p.m. CT, Karim S. Trad, MD, a surgeon at George Washington University School of Medicine and Health Sciences, will present the 12-month follow-up data from the TIF® versus Medical PPI Management of Refractory GERD symptoms (TEMPO) study.
The presentation (Abstract #724) is part of an American Gastroenterological Association (AGA) research forum session, “GERD: Complications and Extraesophageal Presentations,” which will take place in room S106B.
The TEMPO data includes 12-month outcomes from 63 randomized and cross-over patients treated at seven U.S. centers, including three gastroenterology practices and four general surgery practices.
The TEMPO trial was designed to assess the safety and efficacy of the Transoral Incisionless Fundoplication procedure as compared with high-dose PPI therapy to treat symptoms associated with chronic GERD.
The TEMPO investigators will be available for an additional question and answer session on Tuesday May 6 at 9:30-10:30 AM at the EGS DDW Booth #3128.
|TIF Procedure Research and Educational Highlights at DDW:|
|Latest published data and new patient stories.||Sunday, May 4 to Tuesday, May 6|
9:30 a.m. – 4:00 p.m. CT
|EGS DDW Booth #3128|
|American Gastroenterological Association’s Clinical Symposium Different Faces of GERD in 2014||Sunday, May 4, 10:00 – 11:30 AM||Room S502|
|American Society of Gastrointestinal Endoscopy’s Learning Center Endoscopic Hands-on Demonstration Session||Sunday, May 4|
10:30 a.m. – 12:30 p.m. CT
|American Gastroenterological Association’s session GERD: Complications and Extraesophageal Presentations||Monday, May 5 2:30 – 2:45 PM||S106B|
|Q&A with TEMPO study investigators including Karim Trad, MD, principal investigator||Tuesday, May 6|
|EGS DDW Booth #3128|
EndoGastric Solutions did not provide financial support for the following scientific sessions and did not influence the content in any way. However, research presented within these scientific sessions may have been supported by EndoGastric Solutions.